CytoDyn Inc. Deferred Federal Income Tax Expense (Benefit)
CytoDyn Inc. (CYDY) reported Deferred Federal Income Tax Expense (Benefit) of $7.24 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-08-31
- CytoDyn Inc. deferred federal income tax expense (benefit) for fiscal 2026 was $7.24M.
- CytoDyn Inc. deferred federal income tax expense (benefit) for fiscal 2025 was -$2.43M.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month |
|---|---|
| 2026-05-31 | $7.24M 10-K · filed 2026-08-31 |
| 2025-05-31 | -$2.43M 10-K · filed 2026-08-31 |
| 2024-05-31 | $57.00K S-1 · filed 2026-04-22 |